- Home
- IVA vs LPSN Comparison
IVA vs LPSN Comparison
Compare IVA & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- LPSN
- Stock Information
- Founded
- IVA 2011
- LPSN 1995
- Country
- IVA France
- LPSN United States
- Employees
- IVA N/A
- LPSN N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- LPSN EDP Services
- Sector
- IVA Health Care
- LPSN Technology
- Exchange
- IVA Nasdaq
- LPSN Nasdaq
- Market Cap
- IVA 127.0M
- LPSN 108.1M
- IPO Year
- IVA 2020
- LPSN 2000
- Fundamental
- Price
- IVA $2.84
- LPSN $1.17
- Analyst Decision
- IVA Strong Buy
- LPSN Hold
- Analyst Count
- IVA 4
- LPSN 6
- Target Price
- IVA $13.25
- LPSN $1.18
- AVG Volume (30 Days)
- IVA 10.9K
- LPSN 2.2M
- Earning Date
- IVA 03-26-2025
- LPSN 03-05-2025
- Dividend Yield
- IVA N/A
- LPSN N/A
- EPS Growth
- IVA N/A
- LPSN N/A
- EPS
- IVA N/A
- LPSN N/A
- Revenue
- IVA $20,652,523.00
- LPSN $334,736,000.00
- Revenue This Year
- IVA N/A
- LPSN N/A
- Revenue Next Year
- IVA $197.46
- LPSN N/A
- P/E Ratio
- IVA N/A
- LPSN N/A
- Revenue Growth
- IVA N/A
- LPSN N/A
- 52 Week Low
- IVA $1.53
- LPSN $0.45
- 52 Week High
- IVA $4.50
- LPSN $2.73
- Technical
- Relative Strength Index (RSI)
- IVA 69.74
- LPSN 41.48
- Support Level
- IVA $2.58
- LPSN $1.20
- Resistance Level
- IVA $2.80
- LPSN $1.37
- Average True Range (ATR)
- IVA 0.15
- LPSN 0.09
- MACD
- IVA 0.04
- LPSN -0.03
- Stochastic Oscillator
- IVA 81.31
- LPSN 6.06
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.